Pantethine supplement may boost psoriasis ointment results, small trial suggests
Start here
A small clinical trial in 24 psoriasis patients, all receiving standard calcipotriene/betamethasone ointment, found that those who added pantethine tablets — a common nutritional supplement — showed symptom improvement within 12 weeks. Patients with higher baseline cholesterol experienced greater improvement, hinting at a link between lipid metabolism and treatment response. The findings suggest pantethine could serve as a low-cost add-on to topical therapy, though the trial's size limits how far the results can be generalized. Larger controlled studies are still needed to confirm the benefit, define the patients most likely to respond, and establish optimal dosing and safety over longer treatment periods.
Written by a model from the reports · updated 3 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- medicalxpress.comPickCommon nutritional supplement may boost psoriasis treatment, small patient trial suggests
In a trial of 24 psoriasis patients, all applied calcipotriene/betamethasone ointment; those who added pantethine tablets showed symptom improvement within 12 weeks, with greater improvement in patients with higher baseline cholesterol.
Heat trend for this story
Heat now 5·Peak in the comparable set 10 (Oct 27 19:00)·Change over 24h in the comparable set –·Participants now 1
Participants counted above, heat below. The trend compares only the participants observed in full throughout, so its set can be smaller than the heat figure itself. Move the pointer or click the chart for an hour's reading; the left and right arrow keys work too.